205 related articles for article (PubMed ID: 10744622)
1. Bcl-2 overexpression and hypoxia synergistically act to modulate vascular endothelial growth factor expression and in vivo angiogenesis in a breast carcinoma line.
Biroccio A; Candiloro A; Mottolese M; Sapora O; Albini A; Zupi G; Del Bufalo D
FASEB J; 2000 Apr; 14(5):652-60. PubMed ID: 10744622
[TBL] [Abstract][Full Text] [Related]
2. Angiogenic potential of prostate carcinoma cells overexpressing bcl-2.
Fernandez A; Udagawa T; Schwesinger C; Beecken W; Achilles-Gerte E; McDonnell T; D'Amato R
J Natl Cancer Inst; 2001 Feb; 93(3):208-13. PubMed ID: 11158189
[TBL] [Abstract][Full Text] [Related]
3. A radicicol derivative, KF58333, inhibits expression of hypoxia-inducible factor-1alpha and vascular endothelial growth factor, angiogenesis and growth of human breast cancer xenografts.
Kurebayashi J; Otsuki T; Kurosumi M; Soga S; Akinaga S; Sonoo H
Jpn J Cancer Res; 2001 Dec; 92(12):1342-51. PubMed ID: 11749701
[TBL] [Abstract][Full Text] [Related]
4. The redox protein thioredoxin-1 (Trx-1) increases hypoxia-inducible factor 1alpha protein expression: Trx-1 overexpression results in increased vascular endothelial growth factor production and enhanced tumor angiogenesis.
Welsh SJ; Bellamy WT; Briehl MM; Powis G
Cancer Res; 2002 Sep; 62(17):5089-95. PubMed ID: 12208766
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor gene expression in the human breast cancer cell line MX-1 is controlled by O2 availability in vitro and in vivo.
Marxsen JH; Schmitt O; Metzen E; Jelkmann W; Hellwig-Bürgel T
Ann Anat; 2001 May; 183(3):243-9. PubMed ID: 11396794
[TBL] [Abstract][Full Text] [Related]
6. Bcl-2 overexpression in human melanoma cells increases angiogenesis through VEGF mRNA stabilization and HIF-1-mediated transcriptional activity.
Iervolino A; Trisciuoglio D; Ribatti D; Candiloro A; Biroccio A; Zupi G; Del Bufalo D
FASEB J; 2002 Sep; 16(11):1453-5. PubMed ID: 12205045
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor mediated angiogenic potential of pancreatic ductal carcinomas enhanced by hypoxia: an in vitro and in vivo study.
Sipos B; Weber D; Ungefroren H; Kalthoff H; Zühlsdorff A; Luther C; Török V; Klöppel G
Int J Cancer; 2002 Dec; 102(6):592-600. PubMed ID: 12448000
[TBL] [Abstract][Full Text] [Related]
8. p73 Overexpression increases VEGF and reduces thrombospondin-1 production: implications for tumor angiogenesis.
Vikhanskaya F; Bani MR; Borsotti P; Ghilardi C; Ceruti R; Ghisleni G; Marabese M; Giavazzi R; Broggini M; Taraboletti G
Oncogene; 2001 Nov; 20(50):7293-300. PubMed ID: 11704858
[TBL] [Abstract][Full Text] [Related]
9. Wild-type p53 suppresses angiogenesis in human leiomyosarcoma and synovial sarcoma by transcriptional suppression of vascular endothelial growth factor expression.
Zhang L; Yu D; Hu M; Xiong S; Lang A; Ellis LM; Pollock RE
Cancer Res; 2000 Jul; 60(13):3655-61. PubMed ID: 10910082
[TBL] [Abstract][Full Text] [Related]
10. The role of vascular endothelial growth factor in the tissue specific in vivo growth of prostate cancer cells.
Krupski T; Harding MA; Herce ME; Gulding KM; Stoler MH; Theodorescu D
Growth Factors; 2001; 18(4):287-302. PubMed ID: 11519827
[TBL] [Abstract][Full Text] [Related]
11. Enhancement of tumor growth and vascular density by transfection of vascular endothelial cell growth factor into MCF-7 human breast carcinoma cells.
Zhang HT; Craft P; Scott PA; Ziche M; Weich HA; Harris AL; Bicknell R
J Natl Cancer Inst; 1995 Feb; 87(3):213-9. PubMed ID: 7535859
[TBL] [Abstract][Full Text] [Related]
12. Neovascularization in human germ cell tumors correlates with a marked increase in the expression of the vascular endothelial growth factor but not the placenta-derived growth factor.
Viglietto G; Romano A; Maglione D; Rambaldi M; Paoletti I; Lago CT; Califano D; Monaco C; Mineo A; Santelli G; Manzo G; Botti G; Chiappetta G; Persico MG
Oncogene; 1996 Aug; 13(3):577-87. PubMed ID: 8760299
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of vascular endothelial growth factor in a human colon carcinoma cell line transfected with an antisense expression vector specific for c-src.
Ellis LM; Staley CA; Liu W; Fleming RY; Parikh NU; Bucana CD; Gallick GE
J Biol Chem; 1998 Jan; 273(2):1052-7. PubMed ID: 9422768
[TBL] [Abstract][Full Text] [Related]
14. Enhancement of angiogenesis, tumor growth, and metastasis by transfection of vascular endothelial growth factor into LoVo human colon cancer cell line.
Kondo Y; Arii S; Mori A; Furutani M; Chiba T; Imamura M
Clin Cancer Res; 2000 Feb; 6(2):622-30. PubMed ID: 10690548
[TBL] [Abstract][Full Text] [Related]
15. Role of host microenvironment in angiogenesis and microvascular functions in human breast cancer xenografts: mammary fat pad versus cranial tumors.
Monsky WL; Mouta Carreira C; Tsuzuki Y; Gohongi T; Fukumura D; Jain RK
Clin Cancer Res; 2002 Apr; 8(4):1008-13. PubMed ID: 11948107
[TBL] [Abstract][Full Text] [Related]
16. Tumor growth of FGF or VEGF transfected MCF-7 breast carcinoma cells correlates with density of specific microvessels independent of the transfected angiogenic factor.
McLeskey SW; Tobias CA; Vezza PR; Filie AC; Kern FG; Hanfelt J
Am J Pathol; 1998 Dec; 153(6):1993-2006. PubMed ID: 9846989
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of vascular endothelial growth factor by membrane-type 1 matrix metalloproteinase stimulates human glioma xenograft growth and angiogenesis.
Deryugina EI; Soroceanu L; Strongin AY
Cancer Res; 2002 Jan; 62(2):580-8. PubMed ID: 11809713
[TBL] [Abstract][Full Text] [Related]
18. Distinct role of fibroblast growth factor-2 and vascular endothelial growth factor on tumor growth and angiogenesis.
Giavazzi R; Sennino B; Coltrini D; Garofalo A; Dossi R; Ronca R; Tosatti MP; Presta M
Am J Pathol; 2003 Jun; 162(6):1913-26. PubMed ID: 12759248
[TBL] [Abstract][Full Text] [Related]
19. Vascular endothelial growth factor-165 overexpression stimulates angiogenesis and induces cyst formation and macrophage infiltration in human ovarian cancer xenografts.
Duyndam MC; Hilhorst MC; Schlüper HM; Verheul HM; van Diest PJ; Kraal G; Pinedo HM; Boven E
Am J Pathol; 2002 Feb; 160(2):537-48. PubMed ID: 11839574
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibodies against epidermal growth factor and ErbB-2/neu receptor tyrosine kinases down-regulate vascular endothelial growth factor production by tumor cells in vitro and in vivo: angiogenic implications for signal transduction therapy of solid tumors.
Petit AM; Rak J; Hung MC; Rockwell P; Goldstein N; Fendly B; Kerbel RS
Am J Pathol; 1997 Dec; 151(6):1523-30. PubMed ID: 9403702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
